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Abstract 
A 70-year-old woman presented with hypogastric pain. Computed tomography and 
magnetic resonance imaging revealed a retroperitoneal tumor 18.0 cm in diameter 
with fatty tissue density, ventrally compressing the pancreatic head. We suspected a 
well-differentiated liposarcoma compressing the pancreas. At laparotomy, the tumor 
mass was the size of an infant’s head; its center was located in the area corresponding 
to the pancreatic uncus. It was continuous with the pancreatic parenchyma through a 
poorly demarcated border, and we resected as much of the tumor mass as possible 
while conserving the pancreatic capsule. Histopathological examination indicated 
lipomatous pseudohypertrophy of the pancreas with proliferation of mature fatty 
tissue as the main constituent. At the periphery, islands of acinar tissue were retained 
among the fatty infiltration, which also contained branches of the pancreatic duct and 
islets of Langerhans. Previous reports have stated that this disorder only causes fatty 
replacements throughout the pancreas or in the pancreatic body and tail; however, in 
this patient, imaging and macroscopic examination revealed no fatty replacements in 
the pancreatic body and tail. We report this case, which we consider extremely rare, 
along with a brief review of the literature.  
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Introduction 
Lipomatous pseudohypertrophy (LiPH) of the pancreas is an extremely rare disease of 
unknown cause in which pancreatic tissue is replaced by proliferating fatty tissue. In most 
patients either the whole pancreas or only the pancreatic tail enlarges; however, here we 
report an extremely rare case in which LiPH was limited to the pancreatic head.  
Case Report 
The patient was a 70-year-old woman. She had a medical history of angina pectoris and 
hyperlipidemia, and had undergone surgery for an ovarian cystic tumor. She presented to the 
department of internal medicine of our hospital with a one-month history of hypogastric pain. 
Computed tomography (CT) indicated a tumor mass in the dorsal pancreas, and she was therefore 
referred to our department for further investigation and treatment. She was 153.0 cm tall and weighed 
58.0 kg (body mass index 24.8 kg/m
2), and had no clinical signs of anemia or jaundice. The abdomen 
was flat and soft, with no tenderness. The tumor mass was not palpable. Laboratory investigations 
revealed no particular biochemical or hematological abnormalities. Tumor markers and hepatitis 
serology were also negative.  
In CT a tumor mass with a maximum diameter of approximately 18.0 cm was visible, extending 
from the porta hepatis to the hypogastric region. It had the density of fatty tissue, and its interior was 
the same density as soft tissue. The pancreatic head was ventrally compressed and extended, but the 
tumor did not appear to directly invade the pancreas. Mediolaterally, the tumor surrounded the 
superior mesenteric artery and vein (fig. 1). In magnetic resonance imaging (MRI) pancreatic head 
mass lesions were present in the shape of ellipsoids extending from the porta hepatis to anterior to the 
vena cava inferior and reaching the pelvic cavity. On T1- and T2-weighted images, the tumor contained 
areas with similar signal intensity to subcutaneous and intraabdominal fat. Fat suppression MRI 
eliminated the signals from these areas, suggesting that the mass contained adipose tissue (fig. 2).  
Laparotomy revealed a tumor mass with a thin capsule that was primarily located dorsal to the 
duodenum. The mass extended from the hepatoduodenal ligament cranially to dorsal to the transverse 
mesocolon caudally. By means of the Kocher maneuver, the tumor mass, pancreatic head, and 
duodenum were mobilized up to the ligament of Treitz, and the anatomical relationship was 
determined. From the pancreatic uncus the head region was strongly compressed and thinned, and the 
border with the tumor mass was unclear. The pancreatic parenchyma was scattered on the surface of the 
tumor mass. Complete enucleation of the tumor was impossible because the limits of the tumor mass 
capsule could not be clearly identified. We preserved as much of the capsule of the pancreatic head as 
possible to avoid damaging the principal pancreatic duct, and performed resection by partitioning the 
tumor mass. Since we were concerned about creating a pancreatic fistula we sited a pleated drain on the 
inferior surface of the liver and a suction drain on the dorsal pancreas before completing surgery 
(fig. 3).  
Histopathologically the surgical specimen was an elastic and soft, xanthochromatic, lobulated tumor 
mass resembling adipose tissue. Its maximum dimensions were 18.0 × 11.0 × 6.0 cm, and it weighed 
approximately 600 g. The proliferation of mature fatty tissue was observed throughout the tumor mass. 
Islands of acinar tissue were present mainly in the periphery of the tumor mass. The fatty tissue 
contained fine, rudimentary branches of intervening pancreatic duct. Chromogranin A staining 
revealed that islets of Langerhans had remained intact, and cytokeratin 19 staining confirmed the 
presence of pancreatic duct epithelial cells. Whereas the pancreatic duct and islets of Langerhans 
components had remained relatively intact, acinar tissue was damaged and mostly replaced with fat 
infiltration. The presence of dysplastic cells was not seen, and well-differentiated liposarcoma was ruled 
out. Therefore the patient was diagnosed with LiPH of the pancreas (fig. 4). 
On postoperative day 7 (POD7), surgical drainage indicated a pancreatic fistula. Since the amylase 
level in the drainage fluid became elevated at 200,000 IU/l, a continuous infusion of octreotide was 
started, and on POD21 the drain was exchanged for an aspiration drain. Serum trypsin and lipase levels 
at that time were high, and we were convinced that the exocrine function of the remaining pancreas was 
preserved. Since the pancreatic fistula also persisted, endoscopic retrograde cholangio-pancreatography  
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was performed on POD28 to evaluate the principal pancreatic duct, and fortunately major leakage from 
this duct was not identified. From POD35 amylase levels in the drainage fluid started to fall, and the 
amount of fluid drained also decreased. On POD63 drainage was discontinued, and the fistula was 
thought to be almost closed since POD77. The patient was discharged from hospital on POD82. Six 
months later, CT showed no new fat tissue replacing the remaining pancreatic head to body or 
pancreatic tail.  
Discussion 
LiPH of the pancreas is an extremely rare disease that is defined by (1) the enlargement 
and increased weight of the pancreas and morphological uniformity of the pancreas, 
(2) complete replacement of the pancreatic exocrine tissue by fatty tissue, and (3) sparing 
of the pancreatic duct system and islets of Langerhans [1]. A literature search of Japana 
Centra Revuo Medicina and PubMed revealed only 27 other cases worldwide, including 
those in which the condition was diagnosed with imaging alone [1–16]. Unlike steatosis 
resulting from obstruction of the pancreatic duct by pancreatolithiasis or a tumor, the 
causal factors of this disease are unknown. Postulated causative mechanisms include 
congenital anomaly, pancreatic exocrine gland obstruction, and viral infection [2, 13]. 
The reported cases, including the present case, showed a wide range of age distribution 
from 9 months to 80 years, and comprised 16 males and 12 females. Affected sites 
included the entire pancreas (20 cases), body and pancreatic tail (3 cases), pancreatic head 
(4 cases), and uncinate (1 case). Besides the present case, there were only 4 cases in which 
LiPH developed in the pancreatic head [15, 16], hence this distribution appears to be 
extremely rare. The weight of the pancreas varied from 130 g to more than 1,200 g; it was 
at least twice that of the normal pancreas, and in most cases 3 times or more [6, 13]. 
Methods of diagnosis were autopsy (11 cases), surgery after diagnosis of liposarcoma or 
carcinoma (12 cases), and diagnostic imaging alone (5 cases). Symptoms did not 
determine diagnosis, and although many cases were accompanied by abnormal glucose 
tolerance or fatty liver, these abnormalities were not necessarily present [13]. Coexisting 
diseases included cirrhosis of the liver (including that due to hepatitis B) and primary 
sclerosing cholangitis [9, 10, 15], and it seems possible that chronic liver injury influences 
the development of LiPH of the pancreas. Furthermore, cases have been reported in 
which LiPH developed as a complication of squamous cell carcinoma of the pancreas [8], 
so it is also necessary to examine association with malignant tumors. However, in the 
present case there were no obvious associated conditions. 
Concerning differential diagnosis, although symptoms such as abdominal pain and 
anorexia raise the suspicion of liposarcoma, preoperative diagnosis is difficult [13]. In the 
present case, if magnetic resonance cholangio-pancreatography or endoscopic retrograde 
cholangio-pancreatography had been performed prior to surgery, we might have 
identified the pancreatic duct inside the tumor mass as normal. Further, if we had 
performed contrast CT we might have identified the vessel arcade of the pancreatic head 
at the periphery of the tumor mass. 
Regarding intraoperative diagnosis, unfortunately it is generally difficult to diagnose 
fatty tissue by intraoperative frozen section. Indeed, the literature contains only one 
report that a sarcoma could be ruled out in this way [15]. Moreover, we did not 
suspect LiPH from intraoperative findings because the tumor is so rare. Therefore, 
if we had recognized LiPH, and if we could have differentiated between malign and  
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benign manifestations from intraoperative macroscopic findings, we could have 
avoided excessive intrusion and might have prevented postoperative pancreatic 
fistula. At operation, fortunately the pancreatic head was almost normal and 
pancreaticoduodenectomy could be avoided; however, if we had expanded the scope of 
resection the main pancreatic duct would have been damaged, and complications might 
have been exacerbated. There are also reports in which standard pancreatic tail resection 
produced favorable results when the tumor mass was confined to the pancreatic tail 
[5, 13]. Nonetheless, diagnosis requires prudence and resection methods must be selected 
carefully.  
Since LiPH is a benign disorder, conservative management with regular follow-up is 
thought to be sufficient [13]. No specific therapies have been established for LiPH, but 
when symptoms of pancreatic exocrine function insufficiency are present, digestive 
enzymes including pancreatic enzymes are administered [14]. 
The rarity of LiPH of the pancreas means that the growth rate and time span of the 
progression of fat replacement are unknown, but the condition is considered to take 
several years to develop. Moreover, the initial site of LiPH is not clear. LiPH may begin 
from a certain point and gradually spread throughout other regions of the pancreas, it 
may gradually develop throughout the organ, or it may remain confined to a certain area. 
Thus in the present case it is possible that we observed a transitional phase and that the 
whole pancreas would have eventually been replaced by fat. 
Taking the above information into account, we propose to roughly classify LiPH of the 
pancreas by the affected site into diffuse type, head-nodular type and tail-nodular type. 
While tail-nodular type LiPH can be safely resected by removing the pancreatic tail, safe 
resection is difficult in diffuse-type and head-nodular type LiPH, and there are cases in 
which it might be necessary to restrict surgery to biopsy or subtotal resection. It should be 
possible to predict diffuse-type LiPH from diagnostic imaging. We believe that this 
classification is very important when considering treatment options for this condition. In 
the future, we hope that LiPH of the pancreas will be elucidated through long-term 
follow-up and the accumulation of further cases. 
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Fig. 1. Abdominal CT. A mass with the same intensity as fat was recognized in the lower abdomen, 
protruding below the liver. The mass had a maximum diameter of about 18.0 cm. a Axial view. 
b Coronal view. 
 
 
 
Fig. 2. MRI. The mass had high intensity on T1 imaging, and on T2 imaging it had a similar intensity to 
subcutaneous and intraperitoneal fat. Fat suppression eliminated the signals from the mass. a T2. b Fat 
suppression. 
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Fig. 3. Operative findings. The pancreatic uncus and head had been partially replaced by the mass and 
were thin, and the mass did not have clear borders. 
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Fig. 4. Histopathological findings. The operative specimen was yellow, soft, elastic, and lobulated, 
resembling adipose tissue (maximum diameters 18.0 × 11.0 × 6.0 cm), and weighed about 600 g (a). 
Proliferation of mature adipose tissue was seen throughout the mass. Islands of acinar tissue remained 
at the periphery of the tumor mass, and fine pancreatic ducts were present within the fatty tissue (b). 
Immunohistochemical staining of the specimen showed expression of chromogranin A in the islets of 
Langerhans (c), and cytokeratin 19 was detected in the epithelial cells of pancreatic ducts (d). 
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